Actively Recruiting

Age: 18Years +
All Genders
NCT06480955

BOne Metastases REgistry for Patients Undergoing cryoAbLation With curatIve purpoSe

Led by Cardiovascular and Interventional Radiological Society of Europe · Updated on 2025-12-30

50

Participants Needed

5

Research Sites

156 weeks

Total Duration

On this page

Sponsors

C

Cardiovascular and Interventional Radiological Society of Europe

Lead Sponsor

B

Boston Scientific Corporation

Collaborating Sponsor

AI-Summary

What this Trial Is About

BOREALIS is a multicentre, prospective, observational cohort study designed to investigate the effectiveness, feasibility, safety and impact on pain and quality of life of curative-intent cryoablation for the treatment of bone metastases in patients with oligometastatic or bone oligo-progressive disease.

CONDITIONS

Official Title

BOne Metastases REgistry for Patients Undergoing cryoAbLation With curatIve purpoSe

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Bone metastases in patients with oligometastatic disease (<5 bone/visceral metastases) or bone oligo-progressive disease from solid tumors
  • Number of target lesions 4
  • Size of target lesion(s) < 5 cm (largest diameter)
  • Referral to local ablative treatment by multidisciplinary tumour board
  • Treatment planned by percutaneous cryoablation with curative intent assessed as technically feasible
  • Procedure performed with a cryoablation system from Boston Scientific
Not Eligible

You will not qualify if you...

  • Younger than 18 years old
  • Unable or unwilling to give informed consent
  • Ongoing pregnancy
  • Health status not compatible with minimum follow-up of 12 months (Karnofsky Performance Scale < 60%, rapidly evolving tumor histologies with life expectancy < 12 months, or life expectancy < 12 months)
  • Infection at treatment site or systemic infection
  • Uncorrectable coagulopathy
  • Hematological diseases including multiple myeloma and plasmacytoma
  • Concomitant radiation therapy or radiation therapy within 12 weeks before planned cryoablation

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 5 locations

1

Institute Bergonié

Bordeaux, France, 33076

Actively Recruiting

2

CHRU de Strasbourg

Strasbourg, France, 67200

Actively Recruiting

3

Institut Gustave Roussy

Villejuif, France, 94805

Actively Recruiting

4

Hospital Universitario y Politécnico La Fe

Valencia, Spain, 46026

Actively Recruiting

5

CHUV-Lausanne University Hospital

Lausanne, Switzerland, 1011

Actively Recruiting

Loading map...

Research Team

C

Claire E Poulet, PhD

CONTACT

D

Dhwani S. Korde, PhD

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here